CUSMA (NFTA-2) comes into force July 1st 2020! CUSMA, the Canadian, United States and Mexico Agreement (NFTA-2) comes into force tomorrow, July 1st, 2020! Many IP obligations under CUSMA have been ratified through the new Patent Act, Industrial Design Act and Trademarks Act. More changes that will be made through legislative amendments are, for instance: “collective marks”...
COVID 19 Update In view of COVID 19, the Canadian Intellectual Property Office [Patent Office, Trademark Office, & Industrial Design Office] is extending due dates until May 1, 2020 for all matters before CIPO that have a deadline to take action for the period beginning March 16, 2020 and currently ending...
Canadian Patent Blog: New Patent Rules The new Patent Rules were recently published and the long awaited amendments to the Canadian Patent Act are scheduled to come into force on October 30, 2019. These changes to the Patent Rules and Patent Act will substantially alter Canadian practice. A few of these changes...
On October 29th Bill C-86, purposing changes to the Patents Act and Trade-marks Act, was tabled in the House of Commons. Some of the purposed changes to the Patent Act include: Providing rights to the Governor in Council to regulate standard essential patents (patents related to technology that needs to comply...
A business corporation may not have the resources to hire in-house one or more corporate patent or trademark agents to meet their patent needs, but may still require the cost effective value that an in-house patent/trademark agent brings to a business' strategic plan. In such instances a virtual in-house corporate...
In the United States, a patent application may be filed based on an earlier filed “parent” application. Such applications include divisional applications and continuation applications. Continuation application and divisional applications have the same specification as the parent application but normally have different claims. Continuation-in-part (CIP) applications are also available in...
In the Supreme Court decision of Teva Canada Ltd. v. Pfizer Canada Inc. 2012 SCC 60 – Nov 8, 2012 - (Decision varied by SCC in 2013 from pronouncement that patent is not valid to “Teva has established its allegation that Canadian Patent 2,163,446 is not valid) the validity issue...
Costs play an important role for business when making decisions to file and prosecute patent applications through to the grant of patents. These costs can run into the 10’s of thousands of dollars for protection in one or more countries. But the cost of obtaining protection sometimes pales in comparison...
The Canadian Patent Agent Exams are very challenging to pass in one or more sittings. The Exams are written once a year, usually in April and comprise four, four hour exams, written in four consecutive days. The first paper requires evaluation of an invention, prior art and the drafting of...
The First Inventor to Receive a Patent? Filippo Brunelleschi - 1377-1446 - trained as a goldsmith in Florence, is principally known for his eventual work as a structural engineer and architect. At the end of the 13th century a decision was made by the governing body of Florence to construct a...
